Restoration of Endothelial Function by Increasing High‐Density Lipoprotein in Subjects With Isolated Low High‐Density Lipoprotein
暂无分享,去创建一个
M. Hayden | K. Hovingh | J. Kastelein | E. Stroes | J. Levels | P. Lerch | R. Bisoendial | I. Andresen
[1] F. Ruschitzka,et al. High-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic Men , 2002, Circulation.
[2] S. Higano,et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. , 2000, Circulation.
[3] J. E. Doran,et al. Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia , 1996, The Journal of experimental medicine.
[4] A. Zwinderman,et al. Efficacy and Safety of a Novel Cholesteryl Ester Transfer Protein Inhibitor, JTT-705, in Humans: A Randomized Phase II Dose-Response Study , 2002, Circulation.
[5] E. Schiffrin,et al. Correlation of endothelial function in large and small arteries in human essential hypertension. , 2001, Journal of hypertension.
[6] A. Quyyumi,et al. Prognostic Value of Coronary Vascular Endothelial Dysfunction , 2002, Circulation.
[7] Deventer,et al. Distribution and Kinetics of Lipoprotein-Bound Endotoxin , 2001, Infection and Immunity.
[8] M. Freeman,et al. Cellular cholesterol efflux in heterozygotes for tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size. , 2000, Journal of lipid research.
[9] S. Reddy,et al. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. , 2000, Journal of lipid research.
[10] T. Rabelink,et al. Folic acid reverts dysfunction of endothelial nitric oxide synthase. , 2000, Circulation research.
[11] I. Yuhanna,et al. High Density Lipoprotein Prevents Oxidized Low Density Lipoprotein-induced Inhibition of Endothelial Nitric-oxide Synthase Localization and Activation in Caveolae* , 2000, The Journal of Biological Chemistry.
[12] G. Anantharamaiah,et al. A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis. , 2001, Journal of lipid research.
[13] C. Sensen,et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency , 1999, Nature Genetics.
[14] T. Rabelink,et al. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication , 1995, The Lancet.
[15] A M Zeiher,et al. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. , 2000, Circulation.
[16] F. Werf,et al. Malondialdehyde-modified LDL as a marker of acute coronary syndromes. , 1999, JAMA.
[17] M. Hayden,et al. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. , 2000, The Journal of clinical investigation.
[18] T. Rabelink,et al. Cellular regulation of endothelial nitric oxide synthase. , 2001, American journal of physiology. Renal physiology.
[19] D. Sviridov,et al. Apolipoprotein A-I stimulates the transport of intracellular cholesterol to cell-surface cholesterol-rich domains (caveolae). , 2001, The Biochemical journal.
[20] G. Fonarow,et al. formation of , 2022 .
[21] M. Nikolova-Karakashian,et al. High Density Lipoprotein Binding to Scavenger Receptor, Class B, Type I Activates Endothelial Nitric-oxide Synthase in a Ceramide-dependent Manner* , 2002, The Journal of Biological Chemistry.
[22] G. Dagenais,et al. Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Québec Cardiovascular Study) , 1995, The American journal of cardiology.
[23] P. Lerch,et al. Production and Characterization ofa Reconstituted High Density Lipoprotein for Therapeutic Applications , 1996, Vox sanguinis.
[24] Richard G. W. Anderson,et al. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase , 2001, Nature Medicine.
[25] A. Zwinderman,et al. Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study , 2002, The Lancet.
[26] F. Semeria,et al. Intravenous apoA-I/lecithin discs increase pre-beta-HDL concentration in tissue fluid and stimulate reverse cholesterol transport in humans. , 2001, Journal of lipid research.
[27] T. Langmann,et al. Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice , 2000, Nature Genetics.
[28] D. Gordon,et al. High-density lipoprotein--the clinical implications of recent studies. , 1989, The New England journal of medicine.
[29] R. Kirchmair,et al. Effect of insulin therapy on endothelium-dependent dilation in type 2 diabetes mellitus. , 2002, The American journal of cardiology.
[30] T. Wilt,et al. Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group. , 1995, The American journal of cardiology.
[31] J. Deanfield,et al. Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease. , 1997, Circulation.
[32] M. Watkins,et al. Risk Stratification for Postoperative Cardiovascular Events via Noninvasive Assessment of Endothelial Function: A Prospective Study , 2002, Circulation.
[33] D. Maron. The epidemiology of low levels of high-density lipoprotein cholesterol in patients with and without coronary artery disease. , 2000, The American journal of cardiology.
[34] C. Fielding,et al. A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipoprotein A-1. , 2000, Biochemistry.
[35] T. Langmann,et al. Native LDL Upregulation of ATP‐Binding Cassette Transporter‐1 in Human Vascular Endothelial Cells , 2002, Arteriosclerosis, thrombosis, and vascular biology.